Kilitch Drugs (India) Limited (NSE:KILITCH)
India · Delayed Price · Currency is INR 180.99
+5.65 (3.22%)
Jul 15, 2026, 3:29 PM IST
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 6.34 billion as of July 15, 2026. Its market cap has decreased by -7.22% in one year.
Market Cap
6.34B
Enterprise Value
6.51B
Revenue
2.35B
Ranking
n/a
PE Ratio
21.01
Stock Price
180.99
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 6.34B, an increase of 44,125.14%. That is a compound annual growth rate of 28.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 6.34B | 12.34% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 23.32B |
| Indoco Remedies | 22.94B |
| Sakar Healthcare | 20.12B |
| Ind-Swift Laboratories | 19.93B |
| Windlas Biotech | 17.56B |
| Jagsonpal Pharmaceuticals | 15.16B |
| Sigachi Industries | 9.01B |
| Bafna Pharmaceuticals | 5.04B |